Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on January 22, 2008. The report discloses a corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the expansion of the Board of Directors. On January 22, 2008, the Board elected Togo D. West, Jr. as a new director, increasing the total number of directors to eleven. Mr. West was determined to be independent under NYSE Listing Standards.
Management Commentary and Compensation
Mr. West will serve on the Compensation and Management Development Committee and the Committee on Directors and Corporate Governance. He is scheduled to stand for election by stockholders at the Annual Meeting in May 2008. His compensation package includes:
- Annual retainer: $60,000
- Per meeting fee: $2,000
- Annual award of deferred share units: Valued at $110,000 on the date of grant
The filing states there are no related party transactions between the Company and Mr. West.
Investor Verification Checklist
- Confirm the effective date of Togo D. West, Jr.'s board membership (January 22, 2008).
- Verify the new total size of the Board of Directors (eleven members).
- Review the specific committee assignments for the new director.
- Check the upcoming Annual Meeting of Stockholders in May 2008 for the formal election of the new director.